Alpha 1-antitrypsin (alAT), a 52,000-mol-wt serum glycoprotein produced by hepatocytes and mononuclear phagocytes, functions as the major inhibitor of neutrophil elastase. The alAT haplotype S is associated with childhood liver disease and/or adult emphysema when inherited with the Z haplotype to give the phenotype SZ. To accurately identify the SZ phenotype at the level of genomic DNA, four 32P-labeled 19-mer synthetic oligonucleotide probes were prepared; two to identify the M and S difference in exon III, and two to identify the M and Z difference in exon V. These probes were hybridized with various cloned DNAs and genomic DNAs cut with the restriction endonucleases BglI and EcoRI; the genomic DNAs represented all six possible phenotype combinations of the M, S, and Z haplotypes (MM, MS, MZ, SS, ZZ, and SZ). Using the four probes to evaluate 42 samples of genomic DNA, the "at risk" SZ and ZZ phenotypes were correctly identified in all cases, as were the "not at risk" phenotypes SS, MS, MM, and MZ, demonstrating that both exon III and exon V directed probes are necessary to properly identify all of the major "at risk" alAT genes. However, when used to evaluate a very rare family carrying a null allele, these four oligonucleotide probes misidentified the "at risk" null-null and S null phenotypes as "not at risk" MM and SM combinations. These observations indicate that oligonucleotide gene probes yielded reliable and accurate assessment of "at risk" alAT genotypes in almost all situations, but in the context of prenatal diagnosis and genetic counseling this approach must be used with caution and in combination with family studies so as not to misidentify rare genotypes that may be associated with a risk for disease.
Introduction
Alpha 1-antitrypsin (a lAT)', a 52,000-mol-wt serum glycoprotein produced by hepatocytes and mononuclear phagocytes, functions to inhibit neutrophil elastase, a proteolytic enzyme able to destroy all protein components of connective tissue (1) (2) (3) (4) (5) (6) (7) . The a 1AT gene is highly pleomorphic; more than 30 different haplotypes have been described (3, 6) . The a1AT phenotype, referred to as the protease inhibitor (Pi) type, represents the codominant expression of the two parental a 1AT haplotypes (3) . The most common a lAT haplotypes in the USA are those of the M-family (MI, M2, M3; combined haplotype frequency >0.90), the S type (frequency, 0.02-0.04), and the Z type (0.01-0.02) (8) (9) (10) (11) . The clinical interest in these a lAT haplotypes is based on the knowledge that inheritance of the phenotypes PiZZ and PiSZ is associated with an increased risk for the development of emphysema (in adults) and/or liver disease (in children) (12) (13) (14) (15) (16) (17) . Studies at the gene and protein levels have shown that the S and Z genes each code for proteins that differ from the M protein by a single amino acid; in the S protein val264 replaces glu264, while in the Z protein lysM2 replaces glu32 (18) (19) (20) .
The classic approach to detecting the S and Z genes is at the protein level through a combination ofserum isoelectric focusing, serum a1 AT levels, and family studies (21) . However, such studies are often limited by the difficulty in establishing inheritance patterns (e.g., when serum cannot be obtained because family members are deceased or unavailable) or in the context where it is difficult or risky to obtain serum such as for prenatal diagnosis. To circumvent this problem, Kidd et al. (22) developed an approach utilizing synthetic oligonucleotide probes 19 bases in length that, under appropriate hybridization conditions, detected single base differences in the a lAT gene in genomic DNA. Utilizing this approach, they showed that by using two oligonucleotide probes, one complementary to the M gene sequence in exon V and the other complementary to the Z gene sequence in exon V, the homozygous M (PiMM), homozygous Z (PiZZ), and heterozygous MZ (PiMZ) states could be distinguished (22, 23) .
In this context, and in the context of the frequency of the S gene and its potential importance in defining the risk for disease, the present study extends oligonucleotide analysis of the a I AT gene to include the S gene such that all possible "at risk" a IAT phenotypes involving the S, Z, and M genes can be accurately identified. By evaluating 42 individuals with a variety of known a I AT phenotypes, the data show that, with four oligonucleotide probes, two complementary to the M and Z difference in exon V, respectively, and two complementary to the M and S difference in exon III, respectively, accurate diagnosis of all combinations of the S, Z, and M genes are possible at the level of genomic DNA. Most importantly, using four oligonucleotide probes, it is possible to distinguish the "at risk" SZ heterozygote from the "not at risk" MS and MZ heterozygote states, a distinction that has major implications for prenatal diagnosis.
Methods
Study population. The study population consisted of 42 unrelated individuals. Grouped by their alAT serum phenotypes (see below), the population included: MM (n = 11; MIMI = 5, MIM2 = 4, M1M3 = 2); SS (n = 1); ZZ (n = 12); MS (n = 6; MIS 4, M2S = 1, M3S = 1); MZ (n = 8; MIZ = 5, M2Z = 2, M3Z = 1); and SZ (n = 4).
In addition, one family was evaluated in which both the S gene and null gene were carried. The Determination ofalATphenotype. alAT phenotypes (referred to as the "Pi" type) were determined by a combination of isoelectrofocusing, serum alAT levels, and family studies (21) . The isoelectrofocusing of the serum in polyacrylamide at pH 4 to 5 (Serva Fine Biochemicals, Inc., Garden City Park, NY; and Pharmacia Fine Chemicals, Piscataway, NJ) was carried out to achieve maximum separation of alAT M subtypes using a modification of the method of Constans et al. (25, 26) . alAT serum levels were performed by radial immunodiffusion (CalbiochemBehring Corp., La Jolla, CA) according to manufacturer's specification and standards. To avoid confusion with the clinical literature, all serum values reported here will be based on the same commercially available standards, although we, and others (27) , recognize that the available a I AT standards used by clinical laboratories overestimate a I AT serum levels by '-35%. Assignment of a I AT protein phenotype was based on the international nomenclature classification (21) .
Preparation of human genomic DNA. Human genomic DNA was prepared from peripheral white blood cells using a modification of the method of Jeffreys et al. (28) . Briefly, 40 ml of blood was collected into heparinized tubes, followed by mixing with plasmagel (Cellular Products, Inc., Buffalo, NY) in a 1:1 ratio and allowed to separate into two phases at room temperature for 1 h. The upper layer containing white blood cells was centrifuged, and resulting cell pellet was washed and stored at -70'C. The frozen cell suspension was thawed, lysed, and subjected to phenol-chloroform extraction and ethanol precipitation. The DNA precipitate was dissolved in 10 mM Tris-HCI, pH 7.6, 1 mM EDTA, followed by RNAase A and proteinase K digestion and again subjected to phenolchloroform extraction and ethanol precipitation. The and excised the location of the labeled 1 9-mer oligonucleotides (5 mm width). The excised gel was placed in 1 ml of 10 mM Tris-HCl, pH 7.6, and 1 mM EDTA for 2 h, centrifuged, and the supernatant containing the 32P-labeled oligonucleotide probes was stored at -20'C. The separation of the labeled from the unlabeled probe was possible because the 8-mer primers were phosphorylated at the 5' terminus and the elongated 1 9-mer migrated faster than unphosphorylated 1 9-mer templates on the 20% polyacrylamide-8 M urea gel. Thus, the purified probe had a very high specific activity (108 dpm/pmol; 2 X 100' dpm/Mg).
Strategy for evaluation of S mutation using oligonucleotide gene probes. The strategy used for the evaluation of the S mutation of the a IAT gene was a modification of the approach used by Kidd et four oligonucleotide probes showed that the sequence in exon III and V were "M type," demonstrating that it was cloned from a library of an individual who carried at least one M gene (data not shown). These data also demonstrate that, under the conditions used, the synthetic 19-mer oligonucleotide gene probes could adequately discriminate single base differences in the alAT gene, including the difference between the S and M genes. Furthermore, using highly specific activity probes and the hybridization conditions described in Methods, this could be accomplished with a clear hybridization signal without significant background.
Correct identification of various combinations ofS. M, and Z haplotypes usingfour oligonucleotide gene probes. Under the conditions used, the four oligonucleotide gene probes could identify single base differences in exon III and V of the alAT gene using only 5 Atg of total genomic DNA and 2 d of exposure of the autoradiogram (Fig. 3) . Furthermore, this was accomplished with hybridization signals that were highly specific without nonspecific background signals.
Using the exon Ills probe, exon IllM probe, exon Vz probe, and exon VM probe, the a IAT phenotypes MM, SS, ZZ, MS, MZ, and SZ (i.e., all possible combinations of the S, M, and Z haplotypes) could be correctly identified at the genomic DNA level (Fig. 3) genes. Thus, whatever the sequence differences among these three M haplotypes, these differences are not present in these two 19-base sequences.
Of the various S-containing phenotypes (i.e., SS, MS, SZ) evaluated, there was a perfect correlation of the genotype identified with the four oligonucleotide probes and the serum phenotypes (Table I ). This was also true for the Z, non-S-containing phenotype (i.e., ZZ, MZ). Thus, for the relatively common phe- When the entire family was evaluated using the exon 111M, exon Ills, exon VM, and exon Vz oligonucleotide probes, it was clear that the S null phenotype was misidentified at the genomic level as "MS" (Fig. 5) . Likewise, the phenotype Pi null-null (individual 114) was misidentified as "M" and the Pi M null phenotypes (I,, 12, II,, and I12) were also misidentified as "M." In contrast, the four oligonucleotide probes correctly identified the more common phenotypes MM (113) and MS (115). Thus, although a very rare circumstance, the four oligonucleotide probes used in the present study were not sufficient to identify the genotype correctly when the null allele is present. Theoretically, the exception to this statement would be the situation in which the mutation causing the null allele was present among the sequences identified by the exon III and exon V probes used, a 532 T. Nukiwa, M. Brantly, R. Garver, L. Paul, M. Courtney, J.-P. LeCocq, and R. G. Crystal : .: 
Discussion
The inheritance of the a IAT S gene in heterozygote combination with the Z gene is associated with an increased risk of the development ofadult emphysema and childhood liver disease. Using 19-base length oligonucleotide probes, two to identify the M and S differences in exon III of the a lAT gene and two to identify the M and Z difference in exon V, we showed in the present study that all six possible combinations ofthe S, M, and Z alAT genes (SS, SZ, MS, MM, ZZ, MZ) can be accurately identified in genomic DNA. These observations demonstrate that using these four oligonucleotide probes, it is possible to accurately identify the "at risk" a lAT genotype combinations SZ and ZZ in genomic DNA. However, in the circumstance where a very rare "at risk" alAT mutant gene (e.g., the null gene) is inherited with the S or Z gene, because the gene sequence mutation may not be localized to the regions of the alAT gene covered by the exon III and exon V probes, it is possible to misdiagnose an "at risk" alAT genotype combination as "not at risk." However, since the S and Z genes are so much more common than that of any other at risk a 1 AT genes, it is reasonable to suggest that using these four oligonucleotide probes, the vast majority of "at risk" (35-38) .
The S mutant is among the more than 30 a I AT haplotypes that have been identified, and along with the Z haplotype represents one of the two major haplotypes that may place the individual at risk for developing disease (3, 5, 6) . The most frequent alAT haplotypes are those of the M family (MI, M2, M3), together representing at least 90% ofall a I AT haplotypes (6) . The S gene is next in frequency; in the USA, the S haplotypic frequency is 0.02-0.04 (8-1 1) and in Spain and Portugal it is as high as 0. 1 1-0.13 (39, 40) . The Z mutant is close behind, representing 0.0 1-0.02 of all a IAT haplotypes in the USA (8-1 1) and in Europe (41) .
If inherited with an M-family gene or in the homozygous form, the S mutant does not seem to carry with it any risk for developing lung or liver disease or any other disorder. However, epidemiologic studies from the USA and Europe have shown that when inherited with the Z gene, the S gene clearly confers to the affected individual an increased risk for childhood liver disease ( 17) , adult liver disease ( 16, (42) (43) (44) , or emphysema ( 15, (45) (46) (47) . There is no question that, for the SZ heterozygote, the S gene contributes to the risk since when the Z gene is inherited with the M gene, there is no increased risk for the development of emphysema (48) and only a questionable risk for the development of liver disease (49) .
The types of diseases associated with the SZ heterozygote state are similar to that associated with the ZZ homozygote state. The liver disease includes neonatal hepatitis (17) , adult cirrhosis (16, 42, 43) and hepatocellular carcinoma (44) . The emphysema usually develops by age 40 yr and is characterized by destruction ofthe lung parenchyma, first developing in the lower lobes, and it is probably accelerated by cigarette smoking (45, 46, 50) .
Although the ZZ and SZ states have not been compared extensively, the fact that the frequency of the S gene is greater than that of the Z gene, yet there are fewer cases of liver and/ or lung disease reported in association with the SZ state than the ZZ state, suggests that while the S gene carries a clear risk, it is less than that associated with the Z gene. The mechanism by which the S gene is associated with liver disease is unknown. For the lung disease, however, it is assumed that the emphysema associated with the SZ state relates to the fact that these individuals have serum levels thought to be in the range just at or below the threshold level needed by the lung to handle its burden of neutrophil elastase (2, 51) . This concept is consistent with the knowledge that the frequency of emphysema is more common among ZZ individuals (serum levels always <50 mg/dl) than SZ individuals (45-105 mg/dl) (51) .
The reason why the S gene is associated with decreased serum levels of a IAT is unknown. It is not known if the S gene is transcribed normally, ifthe S mRNA is stable, or ifthe S protein functions normally. However, it is reasonable to hypothesize that, like the Z protein, the S protein may get trapped in the rough endoplasmic reticulum because it folds into its tertiary structure more slowly than normal, permitting the S molecules to aggregate through hydrophobic interactions (52) (22, 23) , the ,B-globin idues in length have a high probability of recognizing a unique gene (56) (57) (58) (59) (60) (61) , and the H-ras gene (62 30 haplotypes known, but the molecular basis is known for only two common haplotypes, the Z and S genes, and one rare haplotype (Mpi,^, met358 to arg358) (63) . However, of all the known mutations that do put the affected individual at risk for the development of disease, only the Z and S haplotypes are found in the population in sufficient numbers to be relevant for general diagnostic purposes.
It is clear from the present study, however, that to accurately identify the relatively common at risk phenotypes SZ and ZZ, it is critical to use four probes, two designed to evaluate exon V (the site of the Z mutation) and two designed to evaluate exon III (the site of the S mutation). With this approach it is possible to correctly identify the six phenotypes of the possible combinations of S, M, and Z haplotypes. Since these three haplotypes probably cover >98% ofthe possible occurring aIAT phenotypes (8) and the vast majority of the at risk phenotypes (3), it is reasonable to suggest that such an approach could be used with reasonable certainty for prenatal genotype identification. However, it is also clear that, using only probes for exon V (22, 23) , the relatively frequent S mutation would be scored as "normal" and thus the heterozygote SZ might be misdiagnosed as MZ, a misdiagnosis that may be very relevant in genetic counseling.
Although the combined use of exon III and exon V probes markedly increases the accuracy ofdiagnosis of "at risk" a I AT phenotypes, keep in mind that under extraordinarily rare circumstances it may also lead to incorrect genotype diagnosis with potentially serious consequences. For example, in the family evaluated in which the "null" gene was present, even the use of two exon III and two exon V probes misidentified the M null individuals (family members I,, 12, III, II2) as genotype "M." Furthermore, since the serum a 1AT levels of these individuals were 110-165 mg/dl, without the pedigree analysis, even the combination ofisoelectric focusing, serum a lAT levels, and oligonucleotide probe analysis would likely lead to a misdiagnosis, an obvious problem in genetic counseling. Perhaps more importantly, using oligonucleotide analysis, the null-null individual (114) would be misidentified as genotype "M"; a critical error in the situation ofprenatal diagnosis in which serum was not available. Furthermore, the offspring ofthis individual would be misdiagnosed as MS, although both (III,, III2) were actually phenotype S null. Since the MS phenotype is not a risk, while the S null phenotype will almost certainly develop disease, this could result in a critical error in prenatal diagnosis.
In summary, in view of the frequency of the S haplotype in the general population, and the known association of the SZ phenotype with the risk for disease, it is clear that the use of oligonucleotide probes for a I AT genotype diagnosis cannot depend on probes designed to identify only the Z mutation. In contrast, if probes are used to evaluate the S and Z mutations (i.e., exon III and V, respectively), almost all "at risk" alAT genotypes will be accurately identified. Even so, the known existence of the null haplotype, as well as a few other very rare haplotypes, such as Pi' (64), PiMDuarte (65) , and PiMMalton (66) , demand that the application ofthis methodology to prenatal diagnosis and genetic counseling must always be used with caution and, whenever possible, in conjunction with pedigree studies, a 1 AT serum levels, and isoelectric focusing.
